# A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

> **NCT00119743** · PHASE3 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 5000 (—)

## Conditions studied

- Hepatitis A

## Interventions

- **BIOLOGICAL:** undecavalent pneumococcal-protein D conjugate vaccine

## Key facts

- **NCT ID:** NCT00119743
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-10
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 5000 (—)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00119743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00119743, "A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00119743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*